Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Zylox-Tonbridge Medical Technology Yönetim
Yönetim kriter kontrolleri 2/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Jonathon Zhao
İcra Kurulu Başkanı
CN¥17.4m
Toplam tazminat
| CEO maaş yüzdesi | 17.3% |
| CEO görev süresi | 11.9yrs |
| CEO sahipliği | 12.9% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 3.6yrs |
Son yönetim güncellemeleri
Recent updates
Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher
Oct 02
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business
Sep 27Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon
Apr 23Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate
Jan 18Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?
Sep 21There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price
Aug 03We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?
Mar 08We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥26m |
| Mar 31 2024 | n/a | n/a | -CN¥27m |
| Dec 31 2023 | CN¥17m | CN¥3m | -CN¥79m |
| Sep 30 2023 | n/a | n/a | -CN¥101m |
| Jun 30 2023 | n/a | n/a | -CN¥124m |
| Mar 31 2023 | n/a | n/a | -CN¥119m |
| Dec 31 2022 | CN¥21m | CN¥3m | -CN¥114m |
| Sep 30 2022 | n/a | n/a | -CN¥135m |
| Jun 30 2022 | n/a | n/a | -CN¥155m |
| Mar 31 2022 | n/a | n/a | -CN¥178m |
| Dec 31 2021 | CN¥16m | CN¥2m | -CN¥200m |
| Sep 30 2021 | n/a | n/a | -CN¥168m |
| Jun 30 2021 | n/a | n/a | -CN¥135m |
| Mar 31 2021 | n/a | n/a | -CN¥118m |
| Dec 31 2020 | CN¥10m | CN¥1m | -CN¥100m |
| Dec 31 2019 | CN¥1m | CN¥746k | -CN¥67m |
Tazminat ve Piyasa: Jonathon 'nin toplam tazminatı ($USD 2.47M ), Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 410.05K ).
Tazminat ve Kazançlar: Jonathon 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Jonathon Zhao (56 yo)
11.9yrs
Görev süresi
CN¥17,389,000
Tazminat
Dr. Zhong Zhao also known as Jonathon, serves as Director of Avinger, Inc. since March 04, 2024. He is Founder of Zylox-Tonbridge Medical Technology Co., Ltd. and serves as its Chairman since November 06,...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Founder | 11.9yrs | CN¥17.39m | 12.89% CN¥ 581.2m | |
| Senior VP of Sales & Marketing and Executive Director | 6.6yrs | CN¥10.53m | 0.12% CN¥ 5.6m | |
| Senior VP | 5.8yrs | CN¥8.37m | 1.58% CN¥ 71.1m | |
| Independent Non-Executive Director | 3.6yrs | CN¥200.00k | Veri yok | |
| Non-Executive Director | 3.8yrs | Veri yok | Veri yok | |
| Non-Executive Director | 4yrs | Veri yok | Veri yok | |
| Non Executive Director | 2.4yrs | Veri yok | Veri yok | |
| Independent Non-Executive Director | 3.6yrs | CN¥200.00k | Veri yok | |
| Employee Supervisor | 3.6yrs | Veri yok | Veri yok | |
| Supervisor | 2.4yrs | Veri yok | Veri yok | |
| Chairman of the Board of Supervisors | less than a year | Veri yok | Veri yok | |
| Independent Non-Executive Director | less than a year | Veri yok | Veri yok |
3.6yrs
Ortalama Görev Süresi
51yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 2190 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.6 yıldır).